Trials / Recruiting
RecruitingNCT06617013
GERD in Children With Cystic Fibrosis
Characteristics of Gastroesophageal Reflux in Children With Cystic Fibrosis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 2 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the prevalence of gastroesophageal reflux disease (GERD) symptoms in pediatric patients with cystic fibrosis using the Gastroesophageal Symptom Assessment Scale (GSAS) and the impact of stopping anti-GERD therapy on the GERD symptoms reported.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Discontinuation of GERD therapy | GERD therapy will be discontinued at time of enrollment. |
Timeline
- Start date
- 2024-10-23
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
- First posted
- 2024-09-27
- Last updated
- 2025-12-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06617013. Inclusion in this directory is not an endorsement.